Generic, twice-daily minocycline versus branded, extended-release minocycline for acne: A retrospective comparison of treatment escalation - 14/12/17
Doi : 10.1016/j.jaad.2017.01.013
Preeta Gupta, BS a, ⁎ 
, Timothy Shin, BS a, Jennifer Sopkovich, MD b, Susan Massick, MD b, Benjamin H. Kaffenberger, MD b, ⁎
, Timothy Shin, BS a, Jennifer Sopkovich, MD b, Susan Massick, MD b, Benjamin H. Kaffenberger, MD b, ⁎ a Ohio State University College of Medicine, Columbus, OH
b Division of Dermatology, Ohio State University Wexner Medical Center, Columbus, OH
∗Correspondence to: Preeta Gupta, BS, 915 Olentangy River Rd, Suite 4000, Columbus, OH 43212915 Olentangy River RdSuite 4000ColumbusOH43212∗∗Reprint requests: Benjamin H. Kaffenberger, MD, Ohio State Univeristy Dermatology, 915 Olentangy River Rd, Suite 4000, Columbus, OH 43212Ohio State Univeristy Dermatology915 Olentangy River RdSuite 4000ColumbusOH43212
| Funding sources: Preeta Gupta received funding from The Ohio State University College of Medicine Medical Student Research Scholarship. |
|
| Conflicts of interest: Dr Kaffenberger has received grant funding from the American Acne and Rosacea Society for an unrelated project as well as research funding from Xoma, XBiotech, Biogen, and Celgene for clinical trials and is on the advisory board for Castle Biosciences. The other authors declared no conflicts of interest. |
© 2017
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 76 - N° 6
P. 1195-1197 - juin 2017 Retour au numéro
Article précédent
- Patient-provider race and sex concordance and the risk for medication primary nonadherence
- Adewole S. Adamson, Donald A. Glass, Elizabeth A. Suarez
- The Internet for patient education on atopic dermatitis: Friend or foe?
- Ana Corcimaru, Dean S. Morrell, Craig N. Burkhart
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?